Literature DB >> 3331848

The vitamin D-induced differentiation of HL-60 cells: structural requirements.

V K Ostrem1, H F DeLuca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3331848     DOI： 10.1016/0039-128x(87)90080-8

Source DB:  PubMed          Journal:  Steroids        ISSN： 0039-128X            Impact factor:   2.668


× No keyword cloud information.
  6 in total

1.  Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription.

Authors:  Pawel Grzywacz; Grazia Chiellini; Lori A Plum; Margaret Clagett-Dame; Hector F DeLuca
Journal:  J Med Chem       Date:  2010-11-24       Impact factor: 7.446

2.  The effect of a new vitamin D analog, 22-oxa-1 alpha,25(OH)2D3, on bone mineral metabolism in normal male rats.

Authors:  M Takizawa; M Fallon; B Stein; S Epstein
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

3.  26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25-dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo.

Authors:  Pawel Grzywacz; Lori A Plum; Margaret Clagett-Dame; Hector F DeLuca
Journal:  Bioorg Chem       Date:  2013-02-09       Impact factor: 5.275

4.  Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.

Authors:  Rafal Barycki; Rafal R Sicinski; Lori A Plum; Pawel Grzywacz; Margaret Clagett-Dame; Hector F Deluca
Journal:  Bioorg Med Chem       Date:  2009-09-29       Impact factor: 3.641

5.  26-Desmethyl-2-methylene-22-ene-19-nor-1α,25-dihydroxyvitamin D3 compounds selectively active on intestine.

Authors:  Grazia Chiellini; Pawel Grzywacz; Lori A Plum; Margaret Clagett-Dame; Hector F DeLuca
Journal:  Steroids       Date:  2014-02-07       Impact factor: 2.668

Review 6.  Perspectives in cancer chemoprevention.

Authors:  G D Stoner; M A Morse; G J Kelloff
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.